1. Surgical treatment for gallstones
In recent years, many non-surgical treatment methods for gallstone disease have emerged, some of which were popular for a time, but ultimately failed to pass the test of practice. These include oral medication for dissolving stones, contact dissolution therapy, extracorporeal shock wave lithotripsy, and so on. Some interventional treatments aim to remove stones while preserving the gallbladder, such as percutaneous cholecystoscopy with ultrasound lithotripsy and stone extraction, small incision cholecystotomy for stone extraction, etc. Since the pathological gallbladder, the bed for stone formation, is preserved, there is the drawback of a high recurrence rate of stones. So-called small incision cholecystectomy requires the establishment of a series of delicate work procedures to achieve better results, not just making the incision smaller. After many years of practical testing, surgical treatment remains the preferred method for treating symptomatic gallstones today. Minimally invasive surgery is the current trend in surgery, and laparoscopic cholecystectomy conforms to this trend.
1. Indications for open surgery for gallstones
(1) Gallstones accompanied by acute cholecystitis, onset within 72 hours, with clear surgical indications (suppurative, gangrenous, obstructive).
(2) Recurrent chronic cholecystitis that does not respond to non-surgical treatment, and ultrasound indicates thickening of the gallbladder wall.
(3) Gallstones with symptoms, especially small stones that are prone to impaction.
(4) Atrophy of the gallbladder with no function.
(5) Internal and external fistulas in the gallbladder, especially mucinous fistulas after cholecystostomy.
(6) Gallstones in diabetic patients.
2. Contraindications for open surgery for gallstone
(1) Chronic pain in the upper right abdomen that cannot be explained by gallbladder lesions, and ultrasound and gallbladder imaging did not find any abnormalities in the gallbladder.
(2) The gallbladder should not be removed blindly before the etiology of obstructive jaundice is clarified.
(3) Patients with severe heart, lung, liver, kidney dysfunction or other serious internal diseases that cannot tolerate cholecystectomy.
3. Precautions
Patients with acute cholecystitis who meet the following conditions can be treated with non-surgical methods first, and elective surgery can be performed after the acute phase.
(1) Young patients with mild symptoms during the first attack.
(2) Patients whose condition rapidly improves after conservative treatment.
(3) Patients with atypical clinical symptoms.
(4) Patients with onset of disease for more than 3 days, without urgent surgical indications, and symptoms improved with conservative treatment.
4. Common surgical methods include open cholecystectomy and laparoscopic cholecystectomy. Traditional open surgery is divided into two types: conventional and retrograde resection. If the gallbladder triangle anatomy is abnormal or there is inflammation, edema, severe adhesion that is difficult to separate, the method of combined forward and backward resection can also be used to remove the gallbladder.
(1) Conventional cholecystectomy:
①Exposing and handling the cystic duct: Incise the peritoneum on the left side of the cystic neck along the lateral margin of the hepatoduodenal ligament, carefully separate the cystic duct, and ligate and cut the cystic duct with a clamp 0.5cm away from the common bile duct.
② Treatment of the cystic artery: Anatomize the cystic triangle, find the cystic artery, and pay attention to its relationship with the right hepatic artery. After confirming its distribution to the gallbladder, clamp, cut, and ligate it close to the gallbladder side, and ligate the proximal end in duplicate. If the local anatomical relationship can be clearly identified, the cystic artery can be ligated and cut first in the gallbladder triangle area, and then the cystic duct can be handled. This makes the surgical field clean and bleeding less, allowing the gallbladder duct to be safely pulled to straighten the twisted and spiraling gallbladder duct, making it easy to recognize the relationship with the common bile duct. If the cystic artery is not cut and ligated, it is likely to tear or break the cystic artery when pulling the gallbladder, causing massive bleeding.
③ Removing the gallbladder: At a distance of 1 to 1.5 cm from the liver edge at the subserosal junction between the gallbladder and the liver surface, incise the gallbladder serosa. If there has been recent acute inflammation, the gallbladder can be separated using fingers or a gauze ball along the subserosal loose space under the incised serosa. If the gallbladder wall is thickened and it is difficult to peel off due to adhesion with surrounding tissues, a small amount of sterile normal saline or 0.25% procaine can be injected under the gallbladder serosa, and then the separation is performed. When separating the gallbladder, it can be converged from both ends of the gallbladder bottom and neck to the middle to remove the gallbladder. If there are communicating vessels and wandering bile ducts between the gallbladder and the liver, they should be ligated and cut to prevent postoperative bleeding or bile fistula.
④ Treatment of the liver: After removing the gallbladder, a small amount of oozing bleeding in the gallbladder fossa can be stopped by pressing with a hot saline gauze pad for 3 to 5 minutes. Active bleeding points should be ligated or sutured to stop bleeding. After hemostasis, the serosa on both sides of the gallbladder fossa is sutured with silk thread in an interrupted manner to prevent oozing or adhesion. However, if the gallbladder fossa is wide and the serosa is less, it is not necessarily sutured.
(2) Retrograde cholecystectomy:
① Incision of the gallbladder bottom serosa: Clamp the bottom of the gallbladder with a forceps to pull it, inject a small amount of normal saline under the serosa at a distance of 1 cm from the gallbladder margin around the liver, causing the serosa to swell and float up, and incise the serosa at that location.
② Separation of the gallbladder: Starting from the bottom of the gallbladder, separate the gallbladder from the subserosal space to the body. The ligation and incision during separation must be close to the gallbladder wall. If adhesions are tight and separation is difficult, the bottom of the gallbladder can be incised, and the left index finger can be inserted into the gallbladder as a guide for sharp dissection around the gallbladder wall.
③ Exposure and ligation of the cystic artery: When the separation reaches the neck of the gallbladder, find the cystic artery above and inside, clamp, cut, and ligate the artery close to the gallbladder wall, and ligate the proximal end in duplicate.
④ Separation and ligation of the cystic duct: Clamp the neck of the gallbladder and pull it outward, separate the covering serosa, find the cystic duct, and separate and trace it to the junction with the common bile duct. After seeing the relationship between the two, clamp, cut, and ligate 0.5 cm away from the common bile duct, and then remove the gallbladder. The residual end of the cystic duct is ligated with a medium-sized silk thread and then reinforced with a suture.
(3) Laparoscopic cholecystectomy:
Laparoscopic cholecystectomy has become a mature surgical technique, characterized by minimal trauma, less patient pain, and rapid recovery, which is widely accepted by patients. In 1992, the Department of Surgery of the Chinese Medical Association conducted a survey of 3,986 cases of laparoscopic cholecystectomy in China, and the surgical complications were slightly higher than those of open surgery, so strict control of the indications and contraindications for surgery should be exercised, and technical training should be strengthened.
① Indications:
A, gallstones with symptoms. B, chronic cholecystitis with symptoms. C, gallstones with a diameter greater than 3cm. D, gallstones of the filling type. E, gallbladder protrusive lesions with symptoms and surgical indications. F, acute cholecystitis with symptoms relieved after treatment and surgical indications. G, estimated to be well tolerated by the patient for surgery.
② Contraindications:
B, relative contraindications include: a, Acute attack of calculous cholecystitis. b, Chronic atrophic calculous cholecystitis. c, Secondary common bile duct stones. d, History of upper abdominal surgery. e, Obesity. f. Hernia.
B, absolute contraindications: a, Acute cholecystitis with severe complications, such as empyema, gangrene, perforation, etc. b, Acute pancreatitis due to gallstones. c. Acute cholangitis. d. Primary common bile duct stones and intrahepatic bile duct stones. e, Obstructive jaundice. f, Cholecystoma. g, Suspicious cholecystic protrusive lesions for possible malignancy. h, Liver cirrhosis with portal hypertension. i, Middle and late pregnancy. j, Abdominal infection, peritonitis. Other conditions include chronic atrophic cholecystitis, gallbladder less than 4.5cm×1.5cm, wall thickness >0.5cm (ultrasound measurement). With bleeding disorders, coagulation dysfunction. Incomplete function of important organs, difficult to tolerate surgery and anesthesia, and those with a pacemaker (prohibition of electrocoagulation and electrosection). Poor general condition not suitable for surgery or elderly patients without strong indications for cholecystectomy, diaphragmatic hernia.
The scope of indications for laparoscopic surgery continues to expand with the development of technology. Certain diseases that were originally relative contraindications for surgery are also increasingly being attempted to be completed by laparoscopy. For example, secondary common bile duct stones can already be partially solved by laparoscopic surgery. After gaining the necessary experience, more diseases will be available for laparoscopic surgical treatment.
③ Surgical steps:
A, creating pneumoperitoneum: Make an arc-shaped incision along the inferior margin of the umbilical fossa, about 10mm long. If there has been previous surgery in the lower abdomen, the incision can be made above the umbilicus to avoid the original surgical scar and cut the skin. The operator and the first assistant each hold a towel clamp to lift the abdominal wall from both sides of the umbilical fossa. The operator holds the pneumoperitoneum needle (Veress needle) with the thumb and index finger of the right hand, applies force with the wrist, and inserts the needle vertically or slightly obliquely into the peritoneal cavity. There are two breakthrough sensations when the needle head breaks through the fascia and peritoneum during the puncture process; judge whether the tip of the needle has entered the peritoneal cavity. A syringe filled with physiological saline can be connected, and a negative pressure is present when the needle tip is in the peritoneal cavity. Connect the pneumoperitoneum machine, if the inflation pressure display does not exceed 1.73kPa, it indicates that the pneumoperitoneum needle is in the peritoneal cavity. When starting to inflate, it should not be too fast, use low-flow inflation, 1-2L/min. At the same time, observe the intraperitoneal pressure on the pneumoperitoneum machine; the pressure should not exceed 1.73kPa during inflation. If it is too high, it indicates that the position of the pneumoperitoneum needle is incorrect or the anesthesia is too shallow and the muscles are not sufficiently relaxed, and appropriate adjustments should be made. When the abdomen begins to swell and the liver dullness boundary disappears, high-flow automatic inflation can be changed to until reaching the predetermined value (1.73-2.00kPa), at this time, inflate 3-4L, the patient's abdomen is completely swollen, and the operation can begin.
At the umbilical pneumoperitoneum needle site, lift the abdominal wall with a towel clip, puncture with a 10mm trocar, the first puncture has a certain degree of 'blindness' and is one of the more dangerous steps in laparoscopy, requiring extra caution. Rotate the trocar slowly and insert it evenly, feeling a sudden disappearance of resistance when entering the abdominal cavity. Open the sealed gas valve and gas will escape, indicating successful puncture. Connect the pneumoperitoneum machine to maintain a constant pressure in the abdominal cavity. Then insert the laparoscope and perform punctures at various points under the laparoscope. Generally, puncture 2cm below the xiphoid process and insert a 10mm trocar for the electrocoagulation hook and clip applicator. At 2cm below the right midclavicular line rib margin or 2cm below the lateral edge of the rectus muscle and axillary前线 rib margin, puncture with a 5mm trocar to insert the irrigator and gallbladder fixation forceps. At this point, artificial pneumoperitoneum and preparation are complete.
Due to the risk of accidentally injuring major blood vessels and intestines in the abdominal cavity during the creation of pneumoperitoneum and the first trocar puncture, and the difficulty in discovery during surgery, recently, many people have changed to making a small incision at the umbilicus, finding the peritoneum, and directly inserting the trocar into the abdominal cavity for inflation.
After successful creation of pneumoperitoneum, start the surgical operation. The division of labor in surgery varies from hospital to hospital; in the General Hospital of the People's Liberation Army, the surgeon holds the gallbladder fixation forceps and electrocoagulation hook, responsible for all surgical operations; the first assistant holds the irrigator, responsible for irrigation, aspiration, and assisting in exposing the surgical field; the second assistant holds the laparoscope to ensure that the surgical field is always displayed in the center of the television screen.
B. Dissection of the Calot triangle: Grasp the gallbladder neck or Hartmann's pouch with a forceps and pull it upwards to the right. It is best to pull the gallbladder duct perpendicular to the common bile duct to clearly distinguish the two, but be careful not to angle the common bile duct. Cut the serosa on the gallbladder duct with an electrocoagulation hook, bluntly separate the gallbladder duct and gallbladder artery, and identify the common bile duct and common hepatic duct. Since it is close to the common bile duct, use as little electrocoagulation as possible to avoid accidental injury to the common bile duct. Free the gallbladder duct with an electrocoagulation hook. Make sure to see the relationship between the gallbladder duct and the common bile duct. Place titanium clips as close as possible to the gallbladder neck, ensuring there is enough distance between the clips, with a minimum distance of 0.5cm from the common bile duct. Cut between the clips with scissors, not using electrocautery or electrocoagulation to prevent heat conduction and injury to the common bile duct. Then find the gallbladder artery behind it and place a titanium clip to cut it. After cutting the gallbladder artery, do not pull it too hard to avoid breaking the gallbladder artery, and pay attention to the posterior branch of the gallbladder artery. Carefully剥离 the gallbladder, use electrocoagulation or place titanium clips to stop bleeding.
C. Cholecystectomy: Clamp the gallbladder neck and pull it upwards, carefully剥离 along the gallbladder wall. The assistant should assist in pulling to create a certain tension between the gallbladder and the liver bed. Remove the gallbladder completely and place it above the right lobe of the liver. Stop bleeding on the liver bed with electrocoagulation, rinse carefully with saline, and check for bleeding and bile leakage (place a gauze pad at the hilum of the liver, remove it and check for bile staining). After removing the accumulated fluid in the abdominal cavity, switch the laparoscope to the subxiphoid trocar, leave the umbilical incision open for the next step, which is to remove a gallbladder larger than 1cm containing stones from the relatively loose and easily dilated umbilical incision. If the stones are small, they can also be removed through the puncture hole below the xiphoid process.
D, Removing the gallbladder: Insert a toothed forceps through the trocar at the umbilicus into the peritoneal cavity, grasp the residual end of the gallbladder duct under the monitor, slowly pull the gallbladder into the trocar sheath, and remove it together with the trocar sheath. When gripping the gallbladder, pay attention to place the gallbladder above the liver to avoid the sharp teeth of the forceps from accidentally injuring the intestines. If the stone is large or the gallbladder tension is high, do not pull it out with force to avoid rupture of the gallbladder, leakage of stones and bile into the abdominal cavity. At this time, it can be removed by expanding the incision with a hemostat or by using an expander to expand the incision to 2.0cm, if the stone is too large, the incision can be extended. If bile leaks into the abdominal cavity, use a moist gauze to enter the umbilical incision to absorb the bile clean. If the stone is too large to be removed from the incision, first open the gallbladder, dry the bile in the gallbladder with a suction device, crush the stones and remove them one by one. If stones are found to have fallen into the abdominal cavity, they should be removed thoroughly.
After checking that there is no blood and fluid in the abdominal cavity, remove the laparoscope, open the valve of the trocar to exhaust the carbon dioxide gas in the abdominal cavity, and then remove the trocar. Suture the fascia layer with a fine thread at the incision for the 10mm trocar 1 to 2 times, and close all incisions with sterile adhesive film.
④ Points to note during surgery:
A, Precautions for establishing pneumoperitoneum: When puncturing the abdominal wall in obese patients, the sense of breakthrough is not obvious twice, to confirm that the needle tip is indeed in the peritoneal cavity, connect a syringe filled with saline to the pneumoperitoneum needle, if the saline in the syringe flows into the peritoneal cavity naturally under gravity, it indicates that the puncture needle has entered the peritoneal cavity. Always watch the gas flow gauge during inflation, the pressure should not exceed 1.73kPa at 4L/min, and the abdomen should rise evenly during inflation, and the liver dullness boundary should disappear.
After the pneumoperitoneum is established, to further confirm whether there is adhesion of the intestines at the umbilicus, a Palmer aspiration test can be performed: connect a 10ml syringe filled with normal saline to an 18-gauge needle, puncture into the peritoneal cavity through the umbilicus, at this time the carbon dioxide gas in the peritoneal cavity will push the saline out of the syringe, and only gas enters the needle, indicating that there is no intestine here. If blood is aspirated or fluid cannot be aspirated, it indicates local adhesion. If intestinal fluid is aspirated, it indicates adhesion of the intestines.
B, Precautions for the use of high-frequency electrosurgical knives: The most common injury to the common bile duct and intestines in laparoscopic organ injury should be noted.
The insulating layer of laparoscopic instruments such as electrocoagulation hooks should be intact, and timely replacement should be made when damaged; preoperative preparation should be sufficient, and enema should be performed to eliminate intestinal bloating; low-voltage high-frequency electrocoagulation is safe at 200V, and no ionized sparks should be produced during cutting; for intestinal injury, the operator often fails to find it at the time, so the electrocoagulation instrument should always be placed on the monitor screen during the operation; when the operator uses the electrocoagulation hook, the force should be kept upward (abdominal wall) to prevent the electrocoagulation hook from rebounding and burning surrounding organs.
C, Anatomy of the Calot triangle: It is mainly to prevent biliary duct injury. Abnormal course of the bile duct is common, so special care should be taken. It is not allowed to use electrocoagulation during dissection to prevent injury to the common bile duct, and it is best to use electrocoagulation hooks or dissectors carefully. When the adhesion of the Calot triangle is very severe or congestion and edema are obvious, and the common bile duct cannot be distinguished, it is wise to switch to open surgery.
D, Handling the cystic duct: One of the causes of bile leakage is improper handling of the cystic duct. The cystic duct is short or the cystic duct is thick, the clip is not fully closed, which often makes the handling of the cystic duct difficult. When encountering a short cystic duct, try to clamp the clip on the side of the common bile duct well, keep the gallbladder side open, and drain the bile. The distal end of the gallbladder should be left with sufficient length to prevent the clip from slipping off. When encountering a thick cystic duct, it is first tied with silk thread, and then the clip is applied. Now there are large clips that work well for thick cystic ducts.
E, Intraoperative cholangiography: There are many methods for cholangiography during bile duct surgery. The method used by the General Hospital of the People's Liberation Army is to clamp the cystic duct on the side of the gallbladder during cholangiography, then cut a small incision on the cystic duct, clamp the opening of the catheter with a hemostat, inject contrast agent and take a film, and monitor the operation with a laparoscope during the process. There are now special hemostats for cholangiography, which are very convenient to use.
F, Removal of the gallbladder: The abdominal muscle at the umbilical trocar hole is relatively weak and can be easily separated with hemostats. When the gallbladder stone is large, the neck of the gallbladder is first pulled out through the abdominal wall, the gallbladder is opened to drain the bile, and the stone is removed from the gallbladder with a stone forceps. If the stone is large, it can be crushed inside the gallbladder first and then removed. After removal, the accumulated blood and bile in the incision should be wiped dry. It is absolutely forbidden to pull out the gallbladder with force when the incision is not large enough, which may cause the gallbladder to rupture and the stones to fall into the abdominal cavity. If stones fall into the abdominal cavity, they should be removed in full, otherwise, residual stones may cause abdominal infection and adhesion.
G, Laparoscopic cholecystectomy is a surgery with risks. The entire process of the surgery should be recorded so that the cause can be found in case of surgical complications.
⑤ Main complications:
A, Biliary duct injury: Biliary duct injury is one of the most common and serious complications of laparoscopic cholecystectomy. The incidence of biliary duct injury and bile leakage is about 10%. It should be given sufficient attention. The main cause is the unclear anatomy of the Calot triangle, especially the lack of vigilance for common variations of the common bile duct or the cystic duct. Unintentional thermal injury to the bile duct during the separation of the cystic duct can lead to bile leakage, as there is no bile leakage during the operation. Postoperative necrosis and shedding of tissue in the area of thermal injury can also cause bile leakage. In addition, the gallbladder bed often has a large wandering bile duct, and the electrocoagulation during the operation cannot be completely coagulated, which can also lead to bile leakage. The main manifestations of biliary duct injury are severe upper abdominal pain, high fever, and jaundice. Patients with typical symptoms generally receive timely treatment after surgery; however, a small number of patients may only present with abdominal distension, lack of appetite, and low fever, which may progressively worsen. Close observation of such patients is necessary, as there have been reports of bile accumulation in the abdominal cavity months after surgery. The judgment of whether there is bile leakage mainly relies on ultrasound or CT examination, and then fine needle puncture or radioactive liver and gallbladder scintigraphy is used to confirm under the guidance of ultrasound or CT.
B. Vascular Injury: One type is massive hemorrhage caused by the tip of the needle damaging the abdominal aorta, iliac artery, or mesenteric artery during the creation of pneumoperitoneum and the insertion of the trocar, with reports of deaths due to trocar puncture. Therefore, after the success of pneumoperitoneum, the laparoscope should scan the entire abdomen to prevent the omission of vascular injuries; another type is unclear anatomy at the porta hepatis or accidental clamping of the right hepatic artery or proper hepatic artery due to bleeding from the gallbladder artery, as well as reports of portal vein injury during dissection. There was a report of right liver necrosis caused by accidental clamping of the hepatic artery.
C. Intestinal Injury: Intestinal injury is mostly caused by accidental injury during electrocoagulation, mainly due to the electrocoagulation hook not being placed on the television monitoring screen and not being discovered, leading to postoperative abdominal pain, distension, fever, and severe peritonitis, with a high mortality rate.
D. Postoperative Intraperitoneal Hemorrhage: Postoperative intraperitoneal hemorrhage is also one of the serious complications of laparoscopic surgery. The main damaged areas are the blood vessels near the gallbladder, such as the hepatic artery, portal vein, and abdominal aorta or vena cava damaged during umbilical puncture. It is manifested as hemorrhagic shock, abdominal swelling, and circulatory failure. Immediate laparotomy should be performed to stop the bleeding.
E. Subcutaneous Emphysema: The causes of subcutaneous emphysema are: one is that when creating pneumoperitoneum, the needle of the pneumoperitoneum does not penetrate the abdominal wall, and high-pressure carbon dioxide enters the subcutaneous tissue; the other is that due to a small skin incision, the trocar is inserted very tightly, and the puncture hole of the peritoneum is relatively loose, carbon dioxide gas leaks into the subcutaneous layer of the abdominal wall during surgery. Postoperative examination can find crepitus under the abdomen, which generally does not require special treatment.
F. Others: Such as incisional hernia, incisional infection, and peritoneal abscess, etc.
2. Other Special Therapies
Non-surgical treatment for cholecystolithiasis includes litholysis, stone expulsion, extracorporeal shock wave lithotripsy, and endoscopic stone removal. The first three are non-invasive, and the last one is invasive. Clinical practice has shown that the lesions of cholecystolithiasis are located in the gallbladder. Simply using the aforementioned non-surgical treatments can temporarily remove stones in some patients, but cannot cure the intrinsic lesions of the gallbladder itself. The recurrence of gallstones in the long term is inevitable, so caution should be exercised when choosing non-surgical treatment for cholecystolithiasis.
1. Litholysis Therapy: Currently, the main drugs for litholysis therapy are ursodeoxycholic acid (ursodeoxycholic acid) and chenodeoxycholic acid (chenodeoxycholic acid). Chenodeoxycholic acid (chenodeoxycholic acid) (chenodeoxycholic acid, CDCA) is obtained by processing and extracting from cow bile, with a structure similar to that synthesized physiologically in human liver. It is taken orally in the form of capsules, with a daily dose of 250-1000mg, and the absorption rate reaches 80%-90%. After absorption, it is transported to the liver, where it combines with glycine and bilirubinate and is secreted into the bile ducts through bile. The mechanism of action of chenodeoxycholic acid can be summarized as follows: ① By inhibiting the biosynthesis of cholesterol by restricting the activity of liver HMG-CoA (hepatichydroxymethylglutaryl, coenzyme A); ② Reducing the absorption of cholesterol in the intestines; ③ Reducing the activity of 7α-hydroxylase (7α-hydroxylase) to inhibit the biosynthesis of endogenous bile acids, while also reducing the entry of cholesterol into the exchangeable cholesterol pool; ④ Chenodeoxycholic acid has the effect of increasing low-density lipoprotein in the blood.
However, there are also side effects of chenodeoxycholic acid treatment, mainly including three points: ①Serum transaminase levels increase, usually temporarily, rarely exceeding twice the normal level; ②Serum cholesterol levels continue to rise; ③Diarrhea occurs at high doses. The dosage of chenodeoxycholic acid is: 10-20 mg/kg/day, then most patients' bile is in a non-saturated state of cholesterol, and the ratio of bile acids plus lecithin/cholesterol reaches about 20. The course of chenodeoxycholic acid treatment is 6 months to 2 years, suitable for most small cholesterol stones, patients with gallbladder contraction function, and has little effect on large single stones. Most gallstones in China are mixed stones, and the efficacy of drug treatment is worse. The biggest problem of chenodeoxycholic acid treatment is the recurrence of gallstones after stopping treatment, with 25% to 50% of patients experiencing recurrence, often within 3 months after treatment, with an annual recurrence rate of 10%.
Ursodeoxycholic acid (ursodeoxycholic acid, ursodiol UDCA) is a 7-β isomer of chenodeoxycholic acid. Its effect is better than that of chenodeoxycholic acid, and it has no side effects of chenodeoxycholic acid. The mechanisms of action of the two are different, UDCA has no inhibitory effect on the biosynthesis of cholesterol and bile acids, which can increase the content of UDCA in bile. The side effects of UDCA are few, and the effect may be better. The dosage of UDCA is: 8-13 mg per kilogram of body weight per day, taken in three doses.
The combined application of ursodeoxycholic acid (chenodeoxycholic acid) and ursodeoxycholic acid in equal proportions can enhance the effectiveness of dissolution, while reducing the side effects of each drug when used separately.
In summary, ursodeoxycholic acid and/or UDCA are only effective for cholesterol stones, and are suitable for stones with a diameter less than 1 cm, which can be single or multiple, X-ray permeable, and for patients with good gallbladder function. Continuous medication for half a year to 2 years is effective. Due to the long course of treatment, less than 10% of patients can persist with the treatment. The recurrence rate is high, the drug has side effects, and the drug price is expensive, which limits its application. In recent years, it is often used in combination with shock wave lithotripsy treatment, becoming part of the systemic treatment for gallstones.
2. Extracorporeal Shock Wave Lithotripsy (ESWL): China held the first national academic symposium on extracorporeal shock wave lithotripsy for bile duct diseases in January 1991, reporting 6357 cases of extracorporeal shock wave lithotripsy. ESWL treatment for gallstones has not been widely conducted in China for a long time, but its impact is significant, and the third-generation extracorporeal shock wave lithotripsy machines with high automation have emerged. It is divided into three types according to the different extracorporeal shock wave generators: ①Electrohydraulic shock wave; ②Electromagnetic shock wave, which uses the working principle of electromagnetic pulse generators to crush stones; ③Piezoelectric shock wave, which uses the principle of inverse piezoelectric effect to crush stones.
To completely expel broken gallstone fragments, it is necessary to rely on: ①Natural excretion of fragments; ②Stone expulsion therapy; ③Stone dissolution therapy. The natural excretion rate of gallstones in the gallbladder is less than 1%, and to improve the curative effect of ESWL to a considerable extent, it depends on the progress of stone dissolution and stone expulsion therapy.
3. Stone expulsion therapy: It is mainly based on the effects of some traditional Chinese medicine on increasing bile secretion, promoting gallbladder contraction, and dilating the Oddi sphincter, combined with the understanding of modern medicine to form a combination of traditional Chinese and Western medicine for stone expulsion. The main medicine for stone expulsion using traditional Chinese medicine preparations is Jin Qian Cao, Yin Chen. Secondly, there are Da Huang, Mang Xiao; Western medicine has magnesium sulfate, which has the effects of promoting bile secretion and reducing the tension of the Oddi sphincter, the latter effect is the strongest at 40 minutes after administration. The dosage of magnesium sulfate is 33% solution 10-20ml, taken orally 3 times a day. The main effective method of the combination of traditional Chinese and Western medicine for stone expulsion therapy is mainly in the common bile duct.
4. Contact dissolution: Thistle first reported percutaneous gallbladder catheterization, injection of dissolution agent methyl叔丁醚 (methylten-butylether, MTBE) for contact dissolution. MTBE can quickly and effectively dissolve cholesterol gallstones, with a boiling point of 55.2°C, higher than that of ether, and will not volatilize immediately after entering the human body. Cholesterol gallstones can be dissolved after contacting for about 24 hours.
Application conditions require a small number of gallstones, able to penetrate X-rays, good gallbladder function, no acute inflammation. It must be noted that as much bile as possible should be drained before injection, the specific gravity of MTBE is 0.74, and if bile is present, it will stratify, which will affect the effect of dissolution. The MTBE solution should be changed regularly to ensure effective contact with gallstones. According to comprehensive literature data, the side effects of using this drug to dissolve gallstones include: ①Burning pain in the upper abdomen; ②Inducing enteritis and hemolysis, which often occurs when the drug infusion is too fast; ③Localized liver necrosis and hemorrhagic pneumonia. Animal experiments show that MTBE has a strong hemolytic effect and can produce acute inflammation on the gallbladder mucosa. Therefore, there is a certain risk in using MTBE to dissolve gallstones, and it must be handled with great caution. MTBE cannot be used for bile duct dissolution. So far, dozens of dissolution drugs have been reported, and the dissolution drugs for cholesterol gallstones discussed more often include: compound lauric acid glyceride monostearate, compound citrus oil mixture, etc.